Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) traded at $2.43 at last check on Friday, Nov 20, making a downturn move of -2.02% on its previous day’s price.
Looking at the stock we see that its previous close was $2.48 and the beta (5Y monthly) reads 0.73 with the day’s price range being $2.3750 – 2.5000. The company has a 12-month trailing PE ratio of 0. In terms of its 52-week price range, SONN has a high of $54.6 and a low of $2.23. The company’s stock has gained about -13.52% over that past 30 days.
On the other hand, looking at the outlook for the SONN stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Let’s briefly compare Sonnet (SONN) stock to its peers. We find that today’s price change of -2.02% and -86.09% over the past 12 months for SONN competes that of Bristol-Myers Squibb Company (BMY), which has seen its stock price fall -0.77% in the latest trading session and is +8.37% over the last one year. Another of its peers Amgen Inc (AMGN) has dropped -0.67% today, but is -2.04% down over the past year, while Gilead Sciences Inc (GILD) is also down -2.02% yet its price remains in the red at -86.09% over the same period. Bristol-Myers has a P/E ratio of 0 compared to Sonnet’s 0 and Amgen’s 17.99. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at -0.68% and -0.75%, respectively, in early deals.
Coming back to Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), we note that the average 3-month trading volume was 2.17 Million, while that of the preceding 10-day period stands at 542.1 Million. Current shares outstanding are 13.64 Million.
According to data from Thomson Reuters, insiders hold 5.06% of the company’s shares while institutions hold 3.3%. The data shows that short shares as of October 29, 2020, stood at 1.28 Million at a short ratio of 2.73. This represents a 9.41% Short interest in Shares outstanding on October 29, 2020. Shares short dropped in October from the previous month at 1.47 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -84.16% down in year-to-date price movement.